MADRIGAL PHARMACEUTICALS, INC. (MDGL) Operating income 2016–2025
MADRIGAL PHARMACEUTICALS, INC. (MDGL) annual operating income history from SEC filings — each fiscal year as reported.
-$300.1MFY2025 · since FY2016: -$25.2M → -$300.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$300.1M | +39.7% |
| FY2024 | -$497.9M | -30.8% |
| FY2023 | -$380.5M | -29.6% |
| FY2022 | -$293.6M | -21.1% |
| FY2021 | -$242.5M | -17.3% |
| FY2020 | -$206.7M | -117.6% |
| FY2019 | -$95.0M | -133.4% |
| FY2018 | -$40.7M | -26.9% |
| FY2017 | -$32.1M | -27.1% |
| FY2016 | -$25.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice